Stocks
Novartis (NVS) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 33 061 | 16 389 | 14 726 | 16 389 | 18 286 | 19 768 | ||
| Changes by years, y/y, % | +93% | -50% | -10% | +11% | +12% | -3.4% | |||
Novartis. EBITDA US GAAP, bln rub
Novartis. EBITDA US GAAP, changes, %
Novartis. EBITDA US GAAP, sum by quarters, bln rub
Novartis (NVS) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 4 888 | 4 206 | 4 693 | 5 251 | 5 618 | 19 768 | |
| Changes by years, y/y, % | +18% | +8% | -5% | +9% | +15% | |||
| Changes by quarters, q/q, % | +1% | -14% | +12% | +12% | +7% | |||
